Diagnostic evaluation may include: Detailed neurological examination assessing sensation, reflexes, and motor function Hemoglobin A1c measurement to evaluate recent glycemic control Vitamin B12 levels and methylmalonic acid (if B12 is borderline) Serum protein electrophoresis (SPEP) and immunofixation to screen for paraproteinemia Thyroid function tests, as hypothyroidism can contribute to neuropathic symptoms Comprehensive metabolic panel to assess renal and hepatic function Nerve conduction studies in selected cases with atypical features Management strategies focus on optimizing glycemic control, which remains the most evidence-based intervention for preventing and potentially improving diabetic neuropathy
Seok-yoons team and replies within 24 hours with a procedure outline that distinguishes between wellness support and cosmetic claims and recommends the right combination of procedures and IVs for your specific case and trip length
The FDA collected 480 adverse event reports for compounded tirzepatide products as of April 2025
Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
Importing GLP-1 medications from Canada, Mexico, India, or anywhere else for personal use is technically illegal under FDA rules, even though enforcement is selective
Products that lack this color may not contain the active ingredients at optimal levels
